Your browser doesn't support javascript.
loading
A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa.
Van Loon, Katherine; Mmbaga, Elia J; Mushi, Beatrice P; Selekwa, Msiba; Mwanga, Ally; Akoko, Larry O; Mwaiselage, Julius; Mosha, Innocent; Ng, Dianna L; Wu, Wei; Silverstein, Jordyn; Mulima, Gift; Kaimila, Bongani; Gopal, Satish; Snell, Jeff M; Benz, Stephen Charles; Vaske, Charles; Sanborn, Zack; Sedgewick, Andrew J; Radenbaugh, Amie; Newton, Yulia; Collisson, Eric A.
Afiliación
  • Van Loon K; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
  • Mmbaga EJ; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Mushi BP; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Selekwa M; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Mwanga A; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Akoko LO; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Mwaiselage J; Ocean Road Cancer Institute, Dar es Salaam, Tanzania.
  • Mosha I; Muhimibili National Hospital, Dar es Salaam, Tanzania.
  • Ng DL; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
  • Wu W; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
  • Silverstein J; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California.
  • Mulima G; Kamuzu Central Hospital, Lilongwe, Malawi.
  • Kaimila B; UNC Project-Malawi, Lilongwe, Malawi.
  • Gopal S; UNC Project-Malawi, Lilongwe, Malawi.
  • Snell JM; University of North Carolina, Chapel Hill, North Carolina.
  • Benz SC; University of North Carolina, Chapel Hill, North Carolina.
  • Vaske C; NantOmics/NantHealth, Inc., El Segundo, California.
  • Sanborn Z; NantOmics/NantHealth, Inc., El Segundo, California.
  • Sedgewick AJ; NantOmics/NantHealth, Inc., El Segundo, California.
  • Radenbaugh A; NantOmics/NantHealth, Inc., El Segundo, California.
  • Newton Y; NantOmics/NantHealth, Inc., El Segundo, California.
  • Collisson EA; NantOmics/NantHealth, Inc., El Segundo, California.
Cancer Epidemiol Biomarkers Prev ; 32(10): 1411-1420, 2023 10 02.
Article en En | MEDLINE | ID: mdl-37505926
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) comprises 90% of all esophageal cancer cases globally and is the most common histology in low-resource settings. Eastern Africa has a disproportionately high incidence of ESCC. METHODS: We describe the genomic profiles of 61 ESCC cases from Tanzania and compare them to profiles from an existing cohort of ESCC cases from Malawi. We also provide a comparison to ESCC tumors in The Cancer Genome Atlas (TCGA). RESULTS: We observed substantial transcriptional overlap with other squamous histologies via comparison with TCGA PanCan dataset. DNA analysis revealed known mutational patterns, both genome-wide as well as in genes known to be commonly mutated in ESCC. TP53 mutations were the most common somatic mutation in tumors from both Tanzania and Malawi but were detected at lower frequencies than previously reported in ESCC cases from other settings. In a combined analysis, two unique transcriptional clusters were identified: a proliferative/epithelial cluster and an invasive/migrative/mesenchymal cluster. Mutational signature analysis of the Tanzanian cohort revealed common signatures associated with aging and cytidine deaminase activity (APOBEC) and an absence of signature 29, which was previously reported in the Malawi cohort. CONCLUSIONS: This study defines the molecular characteristics of ESCC in Tanzania, and enriches the Eastern African dataset, with findings of overall similarities but also some heterogeneity across two unique sites. IMPACT: Despite a high burden of ESCC in Eastern Africa, investigations into the genomics in this region are nascent. This represents the largest comprehensive genomic analysis ESCC from sub-Saharan Africa to date.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Prognostic_studies País/Región como asunto: Africa Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Prognostic_studies País/Región como asunto: Africa Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article